(Go: >> BACK << -|- >> HOME <<)

Follow
Maximilian Sprang
Title
Cited by
Cited by
Year
Batch effect detection and correction in RNA-seq data using machine-learning-based automated assessment of quality
M Sprang, MA Andrade-Navarro, JF Fontaine
BMC bioinformatics 23 (Suppl 6), 279, 2022
252022
Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma
O Beck, C Paret, A Russo, J Burhenne, M Fresnais, K Steimel, ...
Cancers 12 (4), 793, 2020
172020
CpG-islands as markers for liquid biopsies of cancer patients
M Sprang, C Paret, J Faber
Cells 9 (8), 1820, 2020
152020
seqQscorer: automated quality control of next-generation sequencing data using machine learning
S Albrecht, M Sprang, MA Andrade-Navarro, JF Fontaine
Genome biology 22, 1-20, 2021
122021
Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1
C Paret, N Lehmann, H Bender, M Sprang, CJ Sommer, D Cana, ...
Cancers 13 (22), 5838, 2021
52021
Analysis of bacterial pangenomes reduces CRISPR dark matter and reveals strong association between membranome and CRISPR-Cas systems
A Rubio, M Sprang, A Garzón, A Moreno-Rodriguez, ME Pachón-Ibáñez, ...
Science Advances 9 (12), eadd8911, 2023
32023
Statistical guidelines for quality control of next-generation sequencing techniques
M Sprang, M Krüger, MA Andrade-Navarro, JF Fontaine
Life Science Alliance 4 (11), 2021
32021
Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL
N Ziegler, M Cortés-López, F Alt, M Sprang, A Ustjanzew, N Lehmann, ...
Oncoimmunology 12 (1), 2184143, 2023
2023
Solid tumors exploit proton-sensing GPR65 for orchestration of an immunosuppressive tumor microenvironment
T Bopp, N Truong-Andrevici, JF Fontaine, M Klein, S Rapp, A Wilson, ...
2023
Unveiling IRF4-steered regulation of context-dependent effector programs in Th17 and Treg cells
A Gabele, M Sprang, M Cihan, S Dietzen, M Klein, G Harms, T Ziesmann, ...
bioRxiv, 2023.09. 14.557376, 2023
2023
El análisis de pangenomas bacterianos ilumina la materia oscura de los sistemas CRISPR-Cas
A Rubio, M Sprang, ME Pachón-Ibáñez, J Pachón, MA Andrade-Navarro, ...
2022
Statistical guidelines for quality control of NGS techniques
M Sprang, M Krüger, MA Andrade-Navarro, JF Fontaine
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
M Fresnais, K Steimel, L Seidmann, DC Wagner, N Vewinger, N Lehmann, ...
The system can't perform the operation now. Try again later.
Articles 1–13